Related Experiment Videos
Amoeba-resisting bacteria and ventilator-associated pneumonia
Bernard La Scola1, Ioanna Boyadjiev, Gilbert Greub
1Unité des Rickettsies, Marseille, France.
Emerging Infectious Diseases
|August 2, 2003
Summary
Amoeba-associated bacteria in intensive care unit (ICU) water may cause ventilator-associated pneumonia (VAP). Detecting these bacteria in patient samples, especially when other causes are negative, is crucial for diagnosis and treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Environmental Health
Background:
- Ventilator-associated pneumonia (VAP) is a significant hospital-acquired infection.
- The role of environmental bacteria, particularly those associated with amoebae, in VAP pathogenesis remains underexplored.
- Intensive care units (ICUs) present unique challenges for infection control due to vulnerable patient populations.
Purpose of the Study:
- To investigate the potential of amoeba-associated bacteria found in ICU water as causative agents of VAP.
- To correlate the presence of these bacteria in the environment and patient samples with VAP development.
- To assess the diagnostic utility of detecting amoeba-associated bacteria in VAP cases.
Main Methods:
- Weekly surveillance of ICU water for amoeba-associated bacteria isolates over six months.
- Collection and analysis of serum and bronchoalveolar lavage (BAL) samples from 30 ICU patients.
- Detection of amoeba-associated bacteria DNA in BAL samples using suicide-polymerase chain reaction.
- Serological testing of patient serum against isolated ICU amoeba-associated bacteria.
Main Results:
- Isolation of 310 amoeba-associated bacteria belonging to 10 species from ICU water.
- Serological conversion (seroconversion) to specific amoeba-associated bacteria (Legionella anisa, Bosea massiliensis) observed in 12 out of 30 patients.
- Detection of amoeba-associated bacteria DNA in BAL samples of two patients who subsequently seroconverted.
- Significant association between seroconversion and VAP, and systemic inflammatory response syndrome (SIRS).
Conclusions:
- Amoeba-associated bacteria present in the ICU environment are potential etiological agents of VAP.
- Seroconversion to these bacteria may serve as an indicator of VAP, particularly when conventional microbiological investigations yield negative results.
- Environmental monitoring and targeted diagnostic approaches for amoeba-associated bacteria could improve VAP management in ICUs.